Announcement on Convening the 2025 Semi-annual Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening the 2025 Semi-annual Performance Briefing
Filed with SSE · · 3 pages · Chinese
Release
Shaanxi Kanghui Pharmaceutical Co., Ltd. on 6ix
Earlier from Shaanxi Kanghui Pharmaceutical
- Announcement on Proposed Change of the Company's Stock Abbreviation
- Announcement on Pledge of Partial Equities by Shareholders Holding More Than 5% of Shares
- Announcement on Change of Company Email Address
- Announcement on Completion of Control Change
- 2025 Semi-annual Report
Later from Shaanxi Kanghui Pharmaceutical
- Announcement on Implementing Change of the Company's Stock Name
- Announcement on Completing Change of Legal Representative and Renewing Business License
- Announcement on Progress in Lawsuit and Receipt of Notice of Withdrawal of Lawsuit
- Notice on Convening the 3rd Extraordinary General Meeting in 2025
- Announcement on Change of Drug Production License
Follow Shaanxi Kanghui Pharmaceutical into a list and get an email when it puts out news.
Follow Shaanxi Kanghui Pharmaceutical